Literature DB >> 17392622

HIV and highly active antiretroviral therapy: dyslipidemia, metabolic aberrations, and cardiovascular risk.

Wei Zou1, Lars Berglund.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392622     DOI: 10.1111/j.1520-037x.2007.03071.x

Source DB:  PubMed          Journal:  Prev Cardiol        ISSN: 1520-037X


× No keyword cloud information.
  4 in total

Review 1.  Metabolic clinic for individuals with HIV/AIDS: a commitment and vision to the future of HIV services.

Authors:  Mohamed H Ahmed; Clare Woodward; Dushyant Mital
Journal:  Cardiovasc Endocrinol       Date:  2017-08-18

2.  Relationship of postprandial nonesterified fatty acids, adipokines, and insulin across gender in human immunodeficiency virus-positive patients undergoing highly active antiretroviral therapy.

Authors:  Guijing Lu; Asha Thomas-Geevarghese; Erdembileg Anuurad; Subhashree Raghavan; Robert Minolfo; Bernard Ormsby; Wahida Karmally; Wafaa M El-Sadr; Jeanine Albu; Lars Berglund
Journal:  Metab Syndr Relat Disord       Date:  2009-06       Impact factor: 1.894

Review 3.  Managing dyslipidemia in HIV/AIDS patients: challenges and solutions.

Authors:  Nazik Elmalaika Os Husain; Mohamed H Ahmed
Journal:  HIV AIDS (Auckl)       Date:  2014-12-17

4.  Single nucleotide polymorphisms in LCAT may contribute to dyslipidaemia in HIV-infected individuals on HAART in a Ghanaian population.

Authors:  Simon Bannison Bani; Kwabena Owusu Danquah; Christian Obirikorang; William K B A Owiredu; Lawrence Quaye; Edmund Muonir Der; Emmanuel Acheampong; Yussif Adams; Peter Paul M Dapare; Moses Banyeh; Enoch Odame Anto; Samuel Asamoah Sakyi
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.